MedTrace Logo

Citicoline as Neuroprotector in Preterm

NCT03966170 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-05-29

No results posted yet for this study

Summary

Citicoline as neuroprotector in preterm

Conditions

  • Pre-Term

Interventions

DRUG

Citicoline

Citicoline as neuroprotector

DRUG

Placebo oral tablet

placebo drug

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • May R Elsheikh, MD · Tanta University - Faculty of Medicine

  • Abeer Salamah, MD · Kafr-Elsheikh University - Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2028-11-30
Completion
2028-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03966170 on ClinicalTrials.gov